Brian P. Sylvester Partner

The FDA recently launched an updated dietary supplement ingredient directory titled "Information on Select Dietary Supplement Ingredients and Other Substances," replacing FDA’s "Dietary Supplement Ingredient Directory," released March 2023.

The U.S. Food & Drug Administration recently published revisions to its multichapter draft guidance for industry on Hazard Analysis and Risk-Based Preventive Controls for Human Food. More specifically, FDA revised the draft Introduction, as well as draft Appendix 1, to address stakeholder comments submitted on prior drafts made available in 2016.

Perkins Coie is pleased to announce the launch of our eighth annual Food & Consumer Packaged Goods Litigation Year in Review.

The U.S. Food and Drug Administration recently released an updated list of guidance documents that the agency plans to publish in draft or final form throughout 2024.

Perkins Coie is pleased to publish its Q4 Food and CPG Legal Trends Report.

Brian Sylvester and Tommy Tobin authored a Food Safety Magazine article titled "Cultivated Meat: How FDA and USDA are Addressing Food Safety" detailing what cultivated meat is, who is in charge of regulating it, the current landscape of the industry, and key takeaways for food safety professionals.

On November 30, 2023, FDA announced the availability of new resources for stakeholders to facilitate compliance with the Food Traceability Rule.

On November 1, 2023, the U.S. Food and Drug Administration (FDA) published a proposed rule to amend Prior Notice requirements for imported human and animal food.

Perkins Coie is pleased to publish its Q3 Food and CPG Legal Trends Report.

In the beauty, cosmetics, and personal care world, companies are preparing to comply with upcoming Modernization of Cosmetics Regulation Act provisions of the Federal Food, Drug and Cosmetic Act, which is going into effect on December 29, 2023.

On September 26, 2023, the U.S. Food & Drug Administration added two new chapters to the agency’s draft guidance: Chapter 11: Food Allergen Program and Chapter 16: Acidified Foods.

Perkins Coie is pleased to announce the launch of our first midyear Food and Consumer Packaged Goods (CPG) Legal Trends Report.

The U.S. Food and Drug Administration (FDA) issued guidance on August 7, 2023, clarifying new requirements for cosmetic facility registrations and product listings under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).

In June 2023, the U.S. Department of Agriculture Food Safety and Inspection Service (USDA-FSIS) issued new Directives and a Notice regarding the regulation of cell cultured food products derived from cell lines of USDA-amenable species.

On July 12, 2023, the U.S. Food and Drug Administration released a public inventory of certain food ingredients that the agency has determined are unsafe because they are unapproved food additives that are not Generally Recognized as Safe when used as intended. Concurrently, FDA also released lists of select chemicals in the food supply—including food ingredients, food contact substances, and contaminants under agency review.

Cell-cultured meat and poultry products have crossed an important milestone on their way to the market. The U.S. Department of Agriculture’s Food Safety and Inspection Service has issued new directives designed to implement the 2019 Formal Agreement between USDA-FSIS and FDA regulating cell-cultured meat.

Brian Sylvester contributed to and edited a first-of-its-kind peer reviewed white paper on food safety considerations for a novel alternative protein product, from a regulator lens, the sole law firm team to do so in a sea of food industry scientists and start-ups.

The Modern Agriculture Foundation is Israel's leading non-profit organization, working to promote the fields of Alternative Protein research, entrepreneurship, and commercial scale manufacturing.

On April 23, President Joe Biden signed into law the Food Allergy Safety, Treatment, Education and Research, or FASTER, Act, S. 578, making sesame the ninth major food allergen under the Federal Food, Drug and Cosmetic Act.

Meat grown outside an animal is no longer simply science fiction, and the market is poised for introduction of a variety of so-called cell-based meat products.

In a global first, in recent days, Singapore greenlighted the marketing of a cell-based meat product for human consumption.